Non-adherence policy

How Allcyte images B and T cell interactions to predict drug response

Having worked out how to make non-adherent primary cells amenable to microscopy, Allcyte GmbH has created a platform for imaging interactions between T cells and B cells that can predict drug responses in hematological cancers.

COO Nikolaus Krall said Allcyte’s approach of studying drug responses in both cancer and immune cells provides more accurate predictions of responses than methods that rely solely on cell lines or primary cancer

Read the full 685 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE